Found 4 Enz. Inhib. hit(s) with Target = 'Nuclear factor of activated T-cells, cytoplasmic 2' TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
